Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Renal Sodium Excretion After Salt Loading in HFpEF
NCT03837470Phase 1Completed
- Start
- May 2019
- Primary completion
- Feb 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of furosemide and sodium chloride in heart failure with preserved ejection fraction (HFpEF). Primary endpoint: Urinary Sodium Excretion at 5 hours. Started May 2019; status: completed.
02
Drugs
furosemidesodium chloride
03
Conditions
heart failure with preserved ejection fraction (HFpEF)
Beyond the preview
Go deeper on NCT03837470.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03837470.